CE stock · LUCD stock

CE vs LUCD · rev $10.28B vs rev $4.3M

Celanese Corporation (CE) versus Lucid Diagnostics Inc (LUCD) — a side-by-side from cached financials, not a winner call.

Celanese Corporation (CE) is a chemicals company listed on US.

Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.

Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.

Latest reported LUCD revenue for 2024-12-31 was $4.3M. Net income was -$45.5M. Revenue was up 79.0% from 2023-12-31 to 2024-12-31. LUCD currently screens at market cap $123.3M.

CE currently screens at market cap $5.92B. LUCD currently screens at market cap $123.3M.

Not investment advice. Open the CE and LUCD stock pages for the full models.

Not investment advice.

Popular Stock Comparisons